1. Introduction {#sec0001}
===============

Ataxia Telangiectasia (A-T) is an autosomal recessive condition associated with cutaneous telangiectasias, cerebellar neurodegeneration, immunodeficiency, respiratory disease and increased cancer risk ([@bib0028]). Defects in the A-T mutated (ATM) gene lead to absent or defective production of ATM protein kinase with roles in repair of double-stranded DNA breaks and regulating cellular responses to oxidative stress ([@bib0018]; [@bib0010]; [@bib0006]). Patients with classical A-T have complete absence of ATM protein or defective ATM protein with no detectable kinase activity ([@bib0016]). A-T patients who have defective ATM protein with limited kinase activity have variant A-T, and typically have milder clinical phenotype.

In classical A-T onset of clinical features occurs at median age 18 months ([@bib0009]) but brain MRI scans early in the disease are often subjectively normal. In older children structural imaging studies (reviewed by Sahama et al. [@bib0032]) report cerebellar atrophy. Although studies have utilised neuroimaging techniques such as diffusion tensor imaging ([@bib0030], [@bib0031]), functional MRI ([@bib0025]), and magnetic resonance spectroscopy ([@bib0020]; [@bib0037]) to investigate brain structure and function in A-T, existing studies have not examined relationships between quantitative imaging findings and severity of neurological status in A-T, or between imaging metrics and age across childhood.

We aim to identify candidate imaging markers of cerebellar health and neurological disability that can be used in future treatment trials in A-T. We hypothesise that abnormalities of cerebellar structure, physiology and cellular health occur in childhood A-T and correlate with neurological disability. To test this hypothesis we use quantitative MRI measures of cerebellar volume, tissue ultrastructural integrity (apparent diffusion coefficient, ADC), and metabolic markers of neuronal viability (N-Acetyl Aspartate), cell turnover / myelin breakdown (choline), excitatory neurotransmission (combined glutamine and glutamate, Glx) and gliosis/glial activation (Inositol and Glx) from the Childhood A-T Neuroimaging Assessment Project (CATNAP). We compare metrics from children and teenagers with A-T to normally developing controls. We explore associations between cerebellar volume, water diffusion and spectroscopic measures, and perform multivariate regression analysis to identify a potential biomarker set for predicting neurological status in childhood A-T.

2. Materials and methods {#sec0002}
========================

2.1. Setting and participant recruitment {#sec0003}
----------------------------------------

We conducted a single centre cross-sectional observational study set in the UK National Paediatric A-T clinic at the Nottingham Children\'s Hospital, a regional paediatric neurosciences centre. The study was approved by UK National Research Ethics Service (14/EM/1175). Informed consent was obtained from participants aged 16 to 18 years, and from parents/guardians of participants aged under 16 years.

Participants in the A-T group were recruited from the UK National Paediatric A-T Clinic. Inclusion criteria: Confirmed diagnosis of A-T, aged 6--18 years. Exclusion criteria: Contra-indication to MRI, concurrent or previous cancer or cancer treatment, other (non-A-T) neurological or neurosurgical condition. Healthy volunteers aged 6--18 years were recruited from local community groups, and excluded if they had contra-indication to MRI or any neurological, neurosurgical or other significant medical condition. Recruitment ran from January 2015 to September 2016. We aimed to recruit 30 participants with A-T and 20 controls. Allowing for 20% participant dropout or imaging data rejection in the A-T group this sample size permits detection of a group difference of imaging biomarkers with effect size *d* = 0.52 with 80% power and α ≤ 0.05.

2.2. Clinical assessment {#sec0004}
------------------------

A-T Neurological Examination Scale Toolkit (A-TNEST) ([@bib0016]) was used to quantify neurological disability in the A-T group. A-TNEST assesses multiple neurological domains (communication, eye movements, ataxia, movement disorder, power, neuropathy), and neurology-related domains (nutrition, growth). For participants who had the A-TNEST administered in the National A-T Clinic within three months prior to the MRI scan, this score was used, otherwise the A-TNEST was performed on the day of the study visit before the scan. The A-TNEST was administered by a fully-qualified paediatric neurologist (WW, GC or MP). The total score expressed as a percentage (where 100% represents no disability) was used in the analyses. Presence of ATM kinase expression was assessed in lymphoblastoid cell lines derived from patients by western blotting. ATM kinase activity was assessed using the same patient-derived lymphoblastoid cell lines by the Taylor laboratory as described previously ([@bib0027]).

2.3. MRI scanning {#sec0005}
-----------------

MRI scanning was performed on 3T Discovery MR750 (GE Healthcare, Milwaukee, WI) with 32-channel head coil, without sedation. In addition to standard paediatric MRI preparation, younger participants were shown an animation to prepare them for MRI ([@bib0034]; [@bib0022]). The multiparametric MRI scan protocol included 3D fast spoiled gradient echo T1-weighted structural MRI (1 mm isotropic resolution, TR = 8.15 ms, TE = 3.172 ms, TI = 900 ms, FOV = 256 × 256 × 156 mm); EPI-based axial diffusion-weighted imaging (participants were scanned with at least one of two sequences, a longer protocol for those tolerating the scan well: TR = 8000 ms, TE = 63 ms, *b* = 1000s/mm^2^, 32 separate non-orthogonal directions, 4 additional *b* = 0 s/mm^2^ images acquired, 2 mm isotropic voxel size, whole brain coverage, number of slices = 66; or shorter protocol if not tolerating the scan well: TR = 8000 ms, TE = 83 ms, *b* = 1000s/mm^2^, 3 orthogonal directions, 0.9 mm × 0.9 mm × 4 mm voxel size, number of averages = 2, whole brain coverage, number of slices = 30); and in a subset of participants single voxel MR spectroscopy ([Fig. 1](#fig0001){ref-type="fig"}) with midline cerebellar voxel location ([@bib0026]) (MEGA-PRESS with GSH editing, TR = 2 s, TE = 131 ms and 128 ON and 128 OFF acquisitions; voxel dimensions *x* = 50 mm *y* = 22 mm *z* = 22 mm; spectral editing using 20 ms sinc-weighted Gaussian pulses at 7.5 ppm (OFF) and 4.54 ppm (ON)).Fig. 1**Examples of magnetic resonance spectroscopy data**. Examples of segmentation of structural imaging data and spectroscopy data for a participants with (top row) and without (bottom row) A-T. Left column shows the segmentation labelling for cerebellar substructures (coloured labels) overlaid on the axial T1-weighted structural image. Note the marked cerebellar atrophy in the participant with A-T. The middle column shows spectroscopy voxel position (rectangle) overlaid on axial T1-weighted structural image, with corresponding spectrum obtained shown in the right column.Fig 1:

2.4. Image processing {#sec0006}
---------------------

T1-weighted images were segmented using Multi-Atlas Label Propagation with Expectation--Maximisation based refinement (MALP-EM) algorithm ([@bib0019]; [@bib0014]), refined with an additional step to remove residual CSF from cerebellar labels by classifying all voxels in the cerebellar region with an intensity lower than a threshold (90th percentile of intensities within the 4th ventricle label) as CSF. Label volumes were recorded for cerebellar hemispheric grey matter, cerebellar hemispheric white matter, vermis lobules I--V, VI--VII and VIII--X, and 4th ventricle ([Fig. 1](#fig0001){ref-type="fig"}). Cerebellar sub-regional volumes were combined to give total cerebellar volume. Volumes from all labels plus additional CSF not covered by the MALP-EM mask (obtained by means of registration and mask propagation with the Colin 27 MNI T1 template ([@bib0015])) were combined to give total intracranial volume. Cerebellar and fourth ventricular volumes were reported as fractional volumes expressed relative to total intracranial volume.

Apparent Diffusion Coefficient (ADC) maps were calculated from *b* = 0 and *b* = 1000 diffusion images using the following formula:$$\text{ADC}\left( i \right) = \frac{\ln\left( {{b_{0}\left( i \right)}\!/\!{b_{1000}\left( i \right)}} \right)}{1000}\, \times \, 10^{6}\, = \, 1000\, \times \,\ln\left( {{b_{0}\left( i \right)}\!/\!{b_{1000}\left( i \right)}} \right)$$

The index *i* represents each voxel on the image grids and the 10^6^ factor is used to transform values into units of mm^2^/s. For the shorter (3-orthogonal direction) diffusion acquisitions we directly compute the ADC map using the *b* = 0 and averaged *b* = 1000 images produced automatically by the MRI scanner. In the case of longer acquisition with 32 directions, correction of eddy current distortions and subject movement was performed using the *eddy_correct* tool implemented in FSL ([@bib0017]). We then selected the three *b* = 1000 vol corresponding to the orthogonal *x, y* and *z* directions and averaged them to subsequently compute the ADC map as above. Non-linear 10 mm spacing B-spline free-form registrations ([@bib0029]) of each ADC map to their corresponding T1-weighted image were performed using MIRTK (<http://github.com/BioMedIA/MIRTK>) to account for inherent spatial distortion of diffusion acquisitions. These were initialised with previously computed linear registrations. Normalised Mutual Information ([@bib0033]) was utilised as similarity measure in all registrations. In the non-linear case, bending energy regularisation ([@bib0036]) with a weight of 0.001 was applied. MALP-EM segmentation labels were used to extract mean cerebellar white matter ADC values. For participants who were able to tolerate both diffusion protocols, the absolute agreement of the cerebellar ADC values from the two acquisitions was tested using type A intraclass correlation. For these participants, the ADC calculated from the 3-direction acquisition was used in the main analysis.

Unedited MEGA-PRESS OFF spectra were analysed between 4ppm-0.2 ppm with LCModel (Version 6.3--1H) ([@bib0024]) using a basis set simulated with TARQUIN ([@bib0038]) to quantify total N-Acetyl Aspartate (tNAA), total creatine (tCr), total choline (tCho), inositol (Ins) and combined glutamine and glutamate (Glx) ([Fig. 1](#fig0001){ref-type="fig"}). No relaxation correction was performed. Values for tNAA, tCho, Ins, and Glx are reported as ratios to tCr, and tNAA is additionally reported as a ratio to tCho. To allow quantification of grey matter and white matter fractions within the spectroscopy voxel, the voxel was aligned with the T1-weighted images which were subsequently segmented into grey and white matter components using SPM (<http://www.fil.ion.ucl.ac.uk/spm/software/spm12>). Intravoxel grey and white matter fractions were derived from aligned segmented images using in-house software.

2.5. Statistical analysis {#sec0007}
-------------------------

Statistical analysis was performed using IBM SPSSv23. Normality of data distribution was assessed by Kolmorgorov-Smirnov test and inspection of histograms. Individual cases were excluded from analyses if the relevant imaging metric was not available due to incomplete acquisition or movement degradation. Group comparisons of distribution of data were by two tailed independent samples T-Test and correlation analysis by Pearson correlation unless stated otherwise. Statistical significance was defined as α \< 0.05, with Bonferroni correction applied where multiple tests were performed unless stated otherwise. Multivariate linear regression analysis was performed between MRI-derived cerebellar measures and A-TNEST. Inclusion of imaging variables as predictor variables was based on significance of α≤0.05 by univariate regression with the dependent variable (A-TNEST score). Backwards removal of predictor variables was performed; the histogram of residuals and scatterplots of the standardised residual against the variable in the adjusted model were inspected to confirm assumptions of linearity and homogeneity of the data.

3. Results {#sec0008}
==========

The A-T group consisted of 22 children and young people (9 females / 13 males, median age 10.8 years, range 6.6--17.8 years). Eleven had no ATM expression, 10 had ATM expression but no kinase activity, and 1 had ATM expression with some residual kinase activity. The control group comprised 24 healthy individuals (12 females/12 males, median age 11.2 years, range 6.5--18.4 years). There was no group difference in age distribution (*t* = 0.006. *P* = 0.995).

A-TNEST data were available for all participants with A-T. Median A-TNEST score was 64% (range 32%−93%) and correlated with age (*r* = −0.548, *P* = 0.008, [Fig. 2](#fig0002){ref-type="fig"}A). No group difference was found in A-TNEST score for those without ATM expression and those with ATM expression but no kinase activity (mean 62.9%, s.d.14.9% vs mean 64.5%, s.d. 13.1% respectively, *P* = 0.863, Independent Samples Mann-Whitney U Test). The A-TNEST score for the participant with residual kinase activity was above scores from similarly aged children with no kinase activity ([Fig. 2](#fig0002){ref-type="fig"}A).Fig. 2**Relationship of age to neurological status and cerebellar volumetry**. Scatterplots of age and (A) A-TNEST score and (B) fractional total cerebellar volume for the A-T group, with line fitted for the whole group. Open squares: participants with no ATM expression; Filled squares: participants with ATM expression but no kinase activity; Star: participant with ATM expression and residual kinase activity. Scatterplot of age and (C) fractional total cerebellar volume and (D) fractional 4th ventricular volume for A-T group (filled blue circles) and control group (open green circles) with 95% confidence intervals.Fig 2:

3.1. Cerebellar volumes are smaller in childhood A-T and show negative linear correlation with age {#sec0009}
--------------------------------------------------------------------------------------------------

Two structural imaging datasets were excluded from the analysis due to excessive movement. Compared to controls, participants with A-T had smaller total cerebellar volumes (mean 5.3%, s.d. 0.9% vs mean 8.7%, s.d. 0.5%, *t* = −15.80, *P* \< 0.005*)* and larger fractional 4th ventricular volume (mean 0.19%, s.d. 0.04% vs mean 0.13%, s.d. 0.04%, *t* = 5.23, *P* \< 0.005*)*. Details of sub-regional fractional cerebellar group differences are given in [Table 1](#tbl0001){ref-type="table"}.Table 1Group comparison of fractional total cerebellar volume, fractional sub-regional cerebellar volumes and fractional 4th ventricular volumes, showing significant differences between the A-T and healthy control groups using independent samples *T*-Test. P-values in bold significant at Bonferroni corrected α \< 0.0071.Table 1:A-T groupHealthy controlsIndependent samples *T*-Test (two tailed)MeanS.D.MeanS.D.*tP*Fractional total cerebellar volume5.3%0.9%8.7%0.5%−15.80**2.8** **×** **10^−19^**Fractional cerebellar hemisphere grey matter volume3.5%0.6%6.0%0.4%−15.71**3.4** **×** **10^−19^**Fractional cerebellar hemisphere white matter volume1.5%0.3%2.1%0.3%−7.07**1.2** **×** **10^−8^**Fractional vermis lobule I-V volume0.15%0.03%0.28%0.03%−13.73**4.0** **×** **10^−17^**Fractional vermis lobule VI-VII volume0.06%0.01%0.11%0.02%−9.06**2.0** **×** **10^−11^**Fractional vermis lobule VIII-X volume0.10%0.03%0.18%0.02%−11.43**1.8** **×** **10^−14^**Fractional 4th ventricular volume0.19%0.04%0.13%0.04%5.23**5** **×** **10^−6^**[^1]

Negative linear correlation was identified between age and fractional total cerebellar volumes for the A-T group (*r* = −0.66, *P* = 0.001, [Fig. 2](#fig0002){ref-type="fig"}B), with positive correlation between these variables for the control group (*r* = 0.45, *P* = 0.026, [Fig. 2](#fig0002){ref-type="fig"}C). Significant difference was found between regression coefficients for A-T and control groups (*t* = −4.48, *P* \< 0.0005). Similar relationships were observed for fractional cerebellar sub-regional volumes (Supplementary fig. 1A-E). The relationship between cerebellar volume and age was similar for A-T participants with absent ATM kinase and those producing non-functioning ATM kinase ([Fig. 2](#fig0002){ref-type="fig"}B). Positive correlation was found between age and fractional 4th ventricular volume for the A-T group (*r* = 0.66, *P* = 0.001) but not the control group (*r* = 0.34, *P* = 0.10) ([Fig. 2](#fig0002){ref-type="fig"}D), but no group difference was found between regression coefficients.

3.2. Cerebellar diffusion is abnormal in childhood A-T independent of cerebellar volume and age {#sec0010}
-----------------------------------------------------------------------------------------------

Diffusion data were available for 19 participants in the A-T group and all control participants. Cerebellar white matter ADC values were elevated in the A-T group compared to controls (adjusted means 0.89 × 10^−3^ mm^2^ s^−1^ vs 0.69 × 10^−3^ mm^2^ s^−1^ respectively, ANCOVA treating diffusion-weighted imaging acquisition method as a covariate of no interest, *F* = 39.6, *P* \< 0.0005). Cerebellar white matter ADC did not correlate with age or fractional cerebellar volume for either group. For the 24 participants who underwent both diffusion protocols, the type A intraclass correlation using an absolute agreement definition for cerebellar white matter ADC values was *r* = 0.75, *P* = 0.001.

3.3. Cerebellar metabolites are altered in childhood A-T independent of cerebellar volume and age {#sec0011}
-------------------------------------------------------------------------------------------------

Twenty-three participants had good quality cerebellar spectroscopy data (12 with A-T, mean age 11.5 years, s.d. 4.1 years; 11 without A-T, mean age 12.5 years, s.d. 2.8 years; no group difference in age distribution: *t* = −0.681. *P* = 0.50). No difference was found between A-T and control groups for the ratio of grey matter to white matter within the spectroscopy voxel (mean 2.37, s.d. 0.81 vs mean 2.63, s.d. 0.55 respectively, *P* = 0.091, Independent Samples Mann--Whitney U Test). Comparison of metabolite ratios using independent samples Mann-Whitney U test due to non-normal distributions showed significant group differences (following Bonferroni correction) for tNAA/tCr, tCho/tCr and tNAA/tCr ([Table 2](#tbl0002){ref-type="table"}). No significant correlations were identified between metabolite ratios and age or fractional cerebellar volume for either the A-T or control groups using Spearman\'s Rho.Table 2Cerebellar metabolite changes in A-T. Metabolite ratios and statistical testing of group differences using Mann--Whitney *U* test are shown. P--values in bold significant at Bonferroni corrected α-value \< 0.0083.Table 2:A-T groupHealthy controlsMann--Whitney *U*MedianRangeMedianRange*P*tNAA/tCr0.990.91--1.391.111.02--1.17**0.002**tCho/tCr0.300.19--0.340.270.24--0.29**0.007**Ins/tCr0.650.55--0.830.620.56--0.680.118Glx/tCr0.480.43--0.660.540.49--0.650.037GSH/tCr0.110.07--0.170.120.11--0.130.118tNAA/tCho3.222.83--7.354.233.71--4.58**0.002**[^2]

3.4. Cerebellar metabolite ratios correlate with ultrastructural white matter integrity in childhood A-T and healthy controls {#sec0012}
-----------------------------------------------------------------------------------------------------------------------------

Partial correlation (controlling for age) showed positive correlation between mean cerebellar white matter ADC and tCho/tCr (*r~partial~* = 0.68, *P* \< 0.001) and negative correlations with tNAA/tCr (*r~partial~* = −0.70, *P* \< 0.001), Glx/tCr (*r~partial~* = −0.55, *P* = 0.008) and tNAA/tCho (*r~partial~* = −0.66, *P* = 0.001) ([Fig. 3](#fig0003){ref-type="fig"}). Positive correlation between mean cerebellar white matter ADC and Ins/tCr (*r~partial~* = 0.50, *P* = 0.018) was not significant at the Bonferroni corrected α \< 0.0083.Fig. 3**Correlations between cerebellar neurometabolites and white matter apparent diffusion coefficient**. Scatterplots showing correlations between cerebellar white matter ADC and (A) tNAA/tCr, (B) tCho/tCr, (C) Glx/tCr and (D) tNAA/tCho. A-T group: filled blue circles; Control group: open green circles.Fig 3:

3.5. Fourth ventricular volume correlates with neurological status in childhood A-T {#sec0013}
-----------------------------------------------------------------------------------

Results of univariate analysis between cerebellar MRI metrics and neurological status are shown in [Table 3](#tbl0003){ref-type="table"}. Three MRI-derived measures met criterion for inclusion in the regression analysis by univariate analysis: Fractional 4th ventricular volume (*r* = −0.53, *P* = 0.015), fractional vermis lobules I-V volume (*r* = 0.46, *P* = 0.041) and Glx/tCr (*r* = 0.59, *P* = 0.045) ([Fig. 4](#fig0004){ref-type="fig"}). However, inclusion of Glx/tCr would have limited the analysis to 12 instead of 20 participants, hence this variable was excluded. The final adjusted model consisted only of fractional 4th ventricular volume achieving *r*^2^~adjusted~ = 0.29, *P* = 0.015 (unstandardized coefficient *B* = −17,456, standard error of *B* = 6523, 95% confidence intervals of B: −31,160 to −3751).Table 3Univariate analysis between cerebellar MRI metrics and neurological status in the A-T group. P-values in bold significant at uncorrected α \< 0.05.Table 3:*nrP*Fractional total cerebellar volume200.220.362Fractional cerebellar hemisphere grey matter volume200.10.572Fractional cerebellar hemisphere white matter volume200.280.233Fractional vermis lobules I-V volume200.46**0.041**Fractional vermis lobules VI-VII volume200.060.802Fractional vermis lobules VIII-X volume200.380.096Fractional 4th ventricular volume20−0.53**0.015**Cerebellar white matter ADC19−0.270.266tNAA/tCr120.41[\*](#tb3fn1){ref-type="table-fn"}0.185tCho/tCr12−0.20[\*](#tb3fn1){ref-type="table-fn"}0.526Ins/tCr120.17[\*](#tb3fn1){ref-type="table-fn"}0.595Glx/tCr120.59[\*](#tb3fn1){ref-type="table-fn"}**0.045**GSH/tCr120.11[\*](#tb3fn1){ref-type="table-fn"}0.742tNAA/tCho120.36[\*](#tb3fn1){ref-type="table-fn"}0.255[^3]Fig. 4**Relationship of neurological status to imaging variables.** Scatterplots for the three imaging variable showing correlation with A-TNEST score on univariate analysis for the A-T group; (A) fractional 4th ventricular volume, (B) fractional vermis lobules I-V volumes and (C) Glx/tCr.Fig 4:

4. Discussion {#sec0014}
=============

We identified age-related profoundly progressive cerebellar volume loss in children and young people with A-T compared to a small linear volume increase in healthy individuals. The divergence is most marked for total cerebellar volume, cerebellar grey matter volumes and superior vermian lobule volumes, but divergence was identified for all cerebellar sub-regions. Our observation that 95% confidence intervals separate towards the end of the first decade ([Fig. 2](#fig0002){ref-type="fig"}C) is consistent with clinical experience that cerebellar atrophy can be difficult to detect by visual inspection of diagnostic MRI scans in the first few years of life for children subsequently confirmed to have A-T, and this may contribute to reported delays in diagnosis of A-T ([@bib0009]). The relationship between cerebellar volume and age was similar for A-T participants with absent ATM kinase production and those producing non-functioning ATM kinase.

Despite the linear relationship between age and fractional cerebellar volume in the A-T group, we did not find correlation between fractional total cerebellar volume and neurological status. We did identify linear relationships between neurological status and both fractional superior vermian lobule volumes and fractional fourth ventricular volume in univariate analysis of 20 participants, with fractional fourth ventricular volume surviving as sole predictor variable for neurological status in multivariate regression analysis. Although it is surprising that cerebellar atrophy is not the strongest correlate of neurological dysfunction, there are potential explanations. The A-TNEST score captures a number of aspects of neurological function, including domains that are not specifically cerebellar, such as extra-pyramidal movement abnormalities. We observed that fractional 4th ventricular volume increased significantly with age in the A-T but not control group, which is likely to be dominated by atrophy of surrounding cerebellar structures including the vermis, cerebellar peduncles, but could also capture subtle atrophy of the dorsal pons, medulla and midbrain. The combination of atrophy of these structures may drive neurological symptoms in A-T explaining the observed correlation with A-TNEST that was not identified for fractional total cerebellar volume alone.

We demonstrate significant elevation of cerebellar white matter ADC in childhood A-T and significant alterations in cerebellar metabolite levels, independent of age and cerebellar volume. ADC provides an index of water mobility, and elevation implies pathological alterations in tissue ultrastructure or increase tissue water content. Sahama and colleagues identified elevated mean diffusivity, a diffusion tensor imaging derived metric related to ADC, in the left cerebellar hemispheric white matter and right superior cerebellar lobule of 11 people with A-T, consistent with our findings ([@bib0030]). This group elegantly demonstrate that loss of white matter integrity extends beyond the cerebellum, with diffusion metrics indicating degeneration along corticomotor, corticospinal and somatosensory pathways ([@bib0031]).

Reduction of cerebellar tNAA ratios was found in the A-T group, using a voxel including cerebellar grey and white matter. tNAA depletion indexes neuronal dysfunction and death ([@bib0011]), and our findings are consistent with classical descriptions of cerebellar grey matter pathology in A-T including loss of Purkinje and granular cells ([@bib0008]). We found tNAA ratios correlated inversely with cerebellar white matter ADC indicating that loss of integrity of cerebellar white matter ultrastructure mirrors neuronal failure, although the causal nature of this association is not clear. The fact that neither of these measures correlates with cerebellar volume suggests ultrastructural disruption and neuronal dysfunction are not directly reflected by cerebellar volume changes. Our finding of cerebellar tNAA depletion replicates previous findings in A-T ([@bib0020]; [@bib0037]), and in particular that reduction in cerebellar tNAA relative to choline distinguishes people with A-T from healthy controls. ([@bib0037])

We demonstrate elevated choline ratios childhood A-T (confirming previous findings in adult A-T ([@bib0037])), and show positive correlation of tCho/tCr with cerebellar white matter ADC. Choline elevation is a marker of myelin turnover observed in conditions associated with demyelination ([@bib0003]), and our findings are consistent with reports of demyelination in A-T ([@bib0035]). ADC is non-specific and indexes alterations in multiple ultrastructural tissue components, but elevated water diffusion is recognised in diseases associated with demyelination ([@bib0002]) which may explain the observed correlation with choline ratios.

Rodent models of A-T demonstrate primary abnormalities of astrocytic cells including slow growth, premature senescence and evidence of oxidative stress ([@bib0023]; [@bib0012]; [@bib0021]). Our results support astroglial abnormalities in A-T; we found positive correlation (uncorrected *P* \< 0.05) between inositol and cerebellar white matter ADC, and mean inositol ratios were higher in the A-T group although the distribution was not significantly different between groups. Inositol is elevated in diseases associated with astrogliosis with recent evidence suggesting inositol elevation may be a relatively late occurrence in the neurodegeneration-related inflammatory cascade ([@bib0011]). We identified lower cerebellar combined glutamine and glutamate (Glx) ratios in the A-T group than controls (uncorrected *P* \< 0.05) and correlation between cerebellar Glx ratios and cerebellar white matter ADC, linking glutamine/glutamate metabolism to underlying tissue integrity in A-T. Although Glx concentrations may relate to proportions of grey and white matter in the sampled volume ([@bib0004]) this is unlikely to be driving our results as we found no group difference in grey:white matter ratio in the spectroscopy voxel. Altered glutamate homeostasis co-occurs with glial activation in the context of neurodegeneration, with reduced glutamine and elevated glutamate associated with increased levels of glutamate dehydrogenase in animal models of progressive neurodegeneration ([@bib0011]). Recent work has shown low serum levels of the glutamate precursor glutamine in ATM-deficient mice, and altered expression of genes related to glutamine metabolism in ATM-deficient mice and humans with A-T ([@bib0005]). Our findings support a role for altered glutamine/glutamate metabolism in A-T but our spectroscopy protocol was not designed to resolve glutamine and glutamate separately limiting our ability to explore pathological mechanisms.

Despite being one of the largest studies using advanced MRI techniques to study childhood A-T, the analysis is limited by small numbers. The rarity of A-T makes it difficult to assemble large cohorts; Multicentre and international collaborations are required to allow sufficient numbers for comprehensive statistical analysis, but this will introduce challenges relating to standardisation of multiparametric MRI protocols ([@bib0001]). Our study focusses on cerebellar imaging metrics, but we acknowledge that pathological changes in the cerebrum and spinal cord ([@bib0008]) could contribute to neurological disability. Another potential limitation is the use of two diffusion protocols, a pragmatic decision made because some participants could not tolerate the longer 32-direction protocol and were scanned with a shorter 3-direction protocol. Previous work shows good reproducibility of ADC values between different scanners and protocols, ([@bib0013]) and from the 24 participants who underwent both diffusion protocols in our study, we find a high intraclass correlation using an absolute agreement definition for the cerebellar white matter ADC values. In addition, we controlled for choice of diffusion protocol in group comparison of ADC values.

5. Conclusion {#sec0015}
=============

Quantitative cerebellar MRI demonstrates differences between children with A-T and controls, provide measures of progressive cerebellar neurodegeneration, and can provide imaging markers of neurological status in childhood A-T. Alterations in metabolites known to be related to neuronal viability, glial activation and myelin turnover relate to loss of cerebellar white matter ultrastructural integrity in childhood A-T. As novel treatment strategies are developed and tested ([@bib0007]), these MRI metrics may be of value in determining timing and impact of interventions aimed at altering the natural history of A-T.

Appendix. Supplementary materials {#sec0017}
=================================
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Summary Statement: Quantitative cerebellar MRI demonstrates progressive cerebellar volume loss and altered neurometabolites indicative of cerebellar injury in children and young people with ataxia telangiectasia, providing potential non-invasive markers of disease status

Supplementary material associated with this article can be found, in the online version, at [doi:10.1016/j.nicl.2019.102110](https://doi.org/10.1016/j.nicl.2019.102110){#interref0003}.

[^1]: S.D. = Standard Deviation.

[^2]: tNAA = total N-Acetyl Aspartate, tCr = total creatine, tCho = total choline, Ins = inositol, Glx = combined glutamine and glutamate, GSH = glutathione.

[^3]: Spearmann rank correlation used in view of small sample size; elsewhere Pearson correlation used. ADC = apparent diffusion coefficient, tNAA = total N-Acetyl Aspartate, tCr = total creatine, tCho = total choline, Ins = inositol, Glx = combined glutamine and glutamate, GSH = glutathione.
